PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cervical Cancer 28,286 Disease Target Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 1 0.00 -0.87 0.25 0.62
Infectious Diseases 33,605 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.62
Meningitis 41,685 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.62
Shock 134,031 Disease Target Glutathione S-Transferase Mu 2 8 2 0.00 -0.87 0.25 0.60
Prostate Cancer 71,064 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.60
Shock 134,031 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.59
Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 4 Target Target Collagen 138,882 1 0.00 -0.87 0.25 0.59
Stroke 146,992 Disease Target E-Selectin/CD62E 4 1 0.00 -0.87 0.25 0.59
Stroke 146,992 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.59
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Carcinoma 433,099 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 2 0.00 -0.87 0.25 0.57
Depression 220,092 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.58
Diabetes 332,602 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.57
Diabetes 332,602 Disease Target E-Selectin/CD62E 4 1 0.00 -0.87 0.25 0.57
Carcinoma 433,099 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.57
Carcinoma 433,099 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.57
Carcinoma 433,099 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.57
Infection 766,637 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target Ck-beta-11 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.55
CCL3 1,427 Target Target CXCL10 2,386 238 0.13 -0.87 0.17 0.83
CCL5 2,002 Target Target CXCL10/IP-10 114 27 0.06 -0.87 0.24 0.76
CCL5 2,002 Target Target CCL8 197 45 0.07 -0.87 0.23 0.78
Platelet Aggregation 25,460 Disease Target Collagen 138,882 5,467 0.09 -0.87 0.21 0.72
DAPK2 27 Target Target DAPK1 205 6 0.08 -0.87 0.22 0.81
Diabetes 332,602 Disease Target Glucagon Receptor 537 131 0.01 -0.87 0.24 0.61
Carcinoma 433,099 Disease Target Cytokeratin 8 587 143 0.01 -0.87 0.24 0.60
Infection 766,637 Disease Target CXCL10 2,386 580 0.01 -0.87 0.24 0.60
Carcinoma 433,099 Disease Target CEA 17,022 4,013 0.05 -0.87 0.24 0.65
CCL7 274 Target Target CCL5 2,002 60 0.08 -0.87 0.22 0.79
Carcinoma 433,099 Disease Target CA 15-3 898 217 0.01 -0.87 0.24 0.60
Cancer 1,053,491 Disease Target Glutathione Peroxidase 2 67 16 0.00 -0.87 0.24 0.56
Infection 766,637 Disease Target Protein Fimh 21 5 0.00 -0.87 0.24 0.56
Infection 766,637 Disease Target CCL3 1,427 339 0.01 -0.87 0.24 0.59
Infection 766,637 Disease Target CXCL2 750 178 0.01 -0.87 0.24 0.59
Cancer 1,053,491 Disease Target Cox-2 21,583 5,031 0.03 -0.87 0.23 0.61
Infection 766,637 Disease Target CCL5 2,002 472 0.01 -0.87 0.24 0.59
CCL3 1,427 Target Target CXCL2 750 123 0.12 -0.87 0.16 0.83
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
Cancer 1,053,491 Disease Target DNA-damage-inducible transcript 3 30 7 0.00 -0.88 0.23 0.56
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
Alpha (Prolastin)- FDA 13 Drug Target Elastase 13,875 3 0.01 -0.88 0.23 0.65
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
Obesity 138,233 Disease Target Acetyl-Coa Carboxylase 1 118 27 0.01 -0.88 0.23 0.62
Bile Salt Export Pump 476 Target Target Multidrug Resistance-Associated Protein 2 462 57 0.12 -0.88 0.12 0.85
Ovarian Cancer 33,996 Disease Target Kallikrein-6 79 18 0.01 -0.88 0.23 0.65
Breast Cancer 173,695 Disease Target CCN5 57 13 0.00 -0.88 0.23 0.60